Design of potent and selective human cathepsin K inhibitors that span the active site

Por Thompson, Scott K., Halbert, Stacie M., Bossard, Mary J., Tomaszek, Thaddeus A., Levy, Mark A., Zhao, Baoguang, Smith, Ward W., Abdel-Meguid, Sherin S., Janson, Cheryl A., D’Alessio, Karla J., McQueney, Michael S., Amegadzie, Bernard Y., Hanning, Charles R., DesJarlais, Renee L., Briand, Jacques, Sarkar, Susanta K., Huddleston, Michael J., Ijames, Carl F., Carr, Steven A., Garnes, Keith T., Shu, Art, Heys, J. Richard, Bradbeer, Jeremy, Zembryki, Denise, Lee-Rykaczewski, Liz, James, Ian E., Lark, Michael W., Drake, Fred H., Gowen, Maxine, Gleason, John G., Veber, Daniel F.
Publicado em 1997